Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | JND4135 |
| Synonyms | |
| Therapy Description |
JND4135 is a pan-NTRK inhibitor with activity against resistance mutations, which potentially leads to decreased tumor growth (PMID: 36235036). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| JND4135 | Trk Receptor Inhibitor (Pan) 33 | JND4135 is a pan-NTRK inhibitor with activity against resistance mutations, which potentially leads to decreased tumor growth (PMID: 36235036). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| NTRK1 G667C | Advanced Solid Tumor | predicted - sensitive | JND4135 | Preclinical - Biochemical | Actionable | In a preclinical study, JND4135 inhibited kinase activity of NTRK1 G667C in an in vitro assay (PMID: 36235036). | 36235036 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|